Registry of images and videos from endoscopic procedures for pancreatic diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to create a clinical registry that collects images and videos from endoscopic ultrasound procedures performed on patients with pancreatic diseases. It will gather historical, pathological, and imaging data from around 12,000 patients, including both retrospective and prospective cases. The focus is on patients with inflammatory pancreatic conditions, autoimmune diseases, and neoplastic conditions, all treated at the Bilio-Pancreatic Endoscopy and Endoscopic Ultrasound Unit of IRCCS San Raffaele Hospital. The data collected will help improve understanding and management of these conditions over a span of nearly three decades.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Suspected or confirmed diagnosis of inflammatory pancreatic disease (e.g., acute, recurrent, or chronic pancreatitis) or autoimmune bilio-pancreatic disease (e.g., autoimmune pancreatitis) or bilio-pancreatic neoplastic disease, necessitating an endoscopic ultrasonography procedure.
* Age over 18 years.
* Ability to provide informed consent.

Exclusion Criteria:

* Pregnancy and breastfeeding status.
* Contraindications to the endoscopic ultrasonography procedure

Where it's running

• IRCCS San Raffaele Hospital
  Milan, Italy Recruiting

Study contacts

• Study coordinator: Matteo Tacelli, MD
• Email: tacelli.matteo@hsr.it
• Phone: 00390226435507

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-based precision oncology clinical trial matching and registry

  This study is testing whether an AI tool can help match cancer patients with the right clinical trials based on their specific cancer details to see if it improves their chances of getting into trials and their overall outcomes.

  Recruiting at 68 sites Massive Bio, Inc. · Birmingham, Alabama and 67 other locations · NCT03452774

• Short-stay aggressive hydration to prevent post-ERCP pancreatitis

  This trial tests whether a short, high-volume IV hydration with Lactated Ringer's plus a rectal indomethacin can prevent post-ERCP pancreatitis in adults undergoing ERCP.

  Recruiting Westmead Hospital · Westmead, New South Wales · NCT07776561

• New DLL3 PET/CT imaging for neuroendocrine tumors compared with standard scans

  A new PET/CT scan using the 68Ga-DLL3 nanobody is being tested to see if it detects metastatic neuroendocrine tumors better than current scans in adults.

  Recruiting at 2 sites Phase 2 Peking University First Hospital · Beijing, Beijing Municipality and 1 other locations · NCT07733024

• Liquid biopsy biomarkers to detect and monitor pancreatic cancer

  Researchers test blood-based microRNA signals to see if they can identify pancreatic cancer risk or early disease in people with familial or hereditary risk or mucinous cysts.

  Recruiting Università Vita-Salute San Raffaele · Milan, MI · NCT07700992

• CTX-471 for NCAM-positive metastatic neuroendocrine tumors

  A phase 2 trial is testing CTX-471 in adults with NCAM (CD56) positive metastatic neuroendocrine tumors that have progressed after standard therapy.

  Recruiting at 2 sites Phase 2 Compass Therapeutics · St Louis, Missouri and 1 other locations · NCT07684170

• Phosphate therapy for adults with acute pancreatitis

  This study tests whether giving phosphate through an IV can help adults with acute pancreatitis treated in the emergency department.

  Recruiting Phase 2 Duke University · Durham, North Carolina · NCT07681050

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.